NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 118 filers reported holding NOVAVAX INC in Q1 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $7,892 | -2.6% | 1,090 | 0.0% | 0.00% | – |
Q2 2023 | $8,099 | +35.1% | 1,090 | +26.0% | 0.00% | – |
Q1 2023 | $5,994 | -13.2% | 865 | +28.7% | 0.00% | – |
Q4 2022 | $6,908 | -59.4% | 672 | -28.8% | 0.00% | – |
Q3 2022 | $17,000 | -69.1% | 944 | -12.2% | 0.00% | -100.0% |
Q2 2022 | $55,000 | -45.0% | 1,075 | -20.5% | 0.00% | -50.0% |
Q1 2022 | $100,000 | -43.2% | 1,352 | +9.8% | 0.00% | -33.3% |
Q4 2021 | $176,000 | -63.6% | 1,231 | -47.1% | 0.00% | -62.5% |
Q3 2021 | $483,000 | +74.4% | 2,329 | +78.3% | 0.01% | +60.0% |
Q2 2021 | $277,000 | -100.0% | 1,306 | -90.2% | 0.01% | -76.2% |
Q1 2021 | $2,427,740,000 | +1028603.4% | 13,390 | +533.1% | 0.02% | +320.0% |
Q4 2020 | $236,000 | +263.1% | 2,115 | +250.7% | 0.01% | +150.0% |
Q3 2020 | $65,000 | +97.0% | 603 | +52.7% | 0.00% | +100.0% |
Q2 2020 | $33,000 | +3200.0% | 395 | +315.8% | 0.00% | – |
Q1 2020 | $1,000 | – | 95 | -34.5% | 0.00% | – |
Q4 2019 | $0 | – | 145 | 0.0% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 145 | -63.3% | 0.00% | – |
Q2 2019 | $2,000 | – | 395 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |